Fulgent Genetics (FLGT) Goodwill (2021 - 2026)

Fulgent Genetics has reported Goodwill for 6 years, with the latest figure at $53.9 million in Q2 2026.

• Quarterly Goodwill rose 144.21% year-over-year to $53.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $53.9 million (up 144.21% YoY) and the FY2025 annual result came in at $25.1 million, up 13.72% from the prior year.
• Goodwill improved to $53.9 million in Q2 2026 per FLGT's latest filing, from $2.7 million in the prior quarter.
• Over five years, Goodwill peaked at $143.1 million in Q1 2023 and troughed at $2.7 million in Q1 2026.
• A 5-year average of $61.2 million and a median of $25.1 million in 2025 frame the typical range for Goodwill.
• The sharpest annual moves came in 2022 and 2026: Goodwill surged 425.18% in 2022, then sank 87.76% in 2026.
• Over 5 years, Goodwill stood at $121.0 million in 2022, then sank by 81.77% to $22.1 million in 2023, then changed by 0.0% to $22.1 million in 2024, then gained by 13.72% to $25.1 million in 2025, then soared by 114.76% to $53.9 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $53.9 million, $2.7 million, and $25.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.